Ezetimibe plus statin versus doubling of statin dose in patients not at target on statin monotherapy: a UK cost-effectiveness study

被引：0
|
作者：
Brady, A. J. B. [1 ]
Davies, G. M. [2 ]
Urdahl, H. [3 ]
Yin, D. [4 ]
Alemao, E. [3 ]
Cook, J. R. [2 ]
机构：
[1] Glasgow Royal Infirm, Dept Med Cardiol, Glasgow G4 0SF, Lanark, Scotland
[2] Merck & Co Inc, Hlth Econ Stat, Upper Gwynedd, PA USA
[3] Merck Sharp & Dohme Ltd, Outcomes Res, Hoddesdon, England
[4] Merck & Co Inc, Outcomes Res, Whitehouse Stn, NJ USA
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：856 / 856
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of ezetimibe coadministration vs doubling statin dose in patients not at cholesterol targets on statin monotherapy in the UK
    Brady, A.
    Davies, G.
    Urdahl, H.
    Yin, D.
    Alemao, E.
    Cook, J.
    [J]. HEART, 2007, 93 : A44 - A44
  • [2] COST-EFFECTIVENESS ANALYSIS OF EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE STATIN DOSE: ANALYSIS OF THE INFORCE STUDY IN THE UK
    Reckless, J. P.
    Davies, G. M.
    Tunceli, K.
    Hu, X. H.
    Brudi, P.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A330 - A330
  • [3] Cost-effectiveness of statin monotherapy and combination therapy with ezetimibe.
    Coleman, CI
    Gillespie, EL
    Gryskiewicz, KA
    White, M
    [J]. PHARMACOTHERAPY, 2005, 25 (03): : 470 - 470
  • [4] A Randomized Trial Comparing the Pleotropic Effects of Ezetimibe Plus Moderate Dose Statin versus High Dose Statin Monotherapy
    Pesaro, Antonio E.
    Serrano, Carlos V., Jr.
    Fernandes, Juliano L.
    Cavalcanti, Alexandre B.
    Campos, Alexandre H.
    Martins, Herlon S.
    Maranhao, Raul C.
    de Lemos, James A.
    Souza, Heraldo P.
    Nicolau, Jose C.
    [J]. CIRCULATION, 2010, 122 (21)
  • [5] Effects of Statin Monotherapy Versus Statin Plus Ezetimibe Combination on Serum Uric Acid Levels
    Moutzouri, Elisavet
    Liberopoulos, Evangelos N.
    Florentin, Matilda
    Liamis, George
    Elisaf, Moses S.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 18 (01) : 13 - 18
  • [6] Cost-effectiveness of statin therapy in categories of patients in the UK
    Mihaylova, B.
    Wu, R.
    Williams, C.
    Zhou, J.
    Schlackow, I.
    Emberson, J.
    Reith, C.
    Keech, A.
    Robson, J.
    Wilkinson, K.
    Armitage, J.
    Collins, R.
    Gray, A.
    Simes, J.
    Baigent, C.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 2841 - 2841
  • [7] A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy
    Nakamura, Takamitsu
    Hirano, Mitsumasa
    Kitta, Yoshinobu
    Fujioka, Daisuke
    Saito, Yukio
    Kawabata, Ken-ichi
    Obata, Jun-ei
    Watanabe, Yosuke
    Watanabe, Kazuhiro
    Kugiyama, Kiyotaka
    [J]. JOURNAL OF CARDIOLOGY, 2012, 60 (1-2) : 12 - 17
  • [8] Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study
    Reckless, John
    Davies, Glenn
    Tunceli, Kaan
    Hu, X. Henry
    Brudi, Philippe
    [J]. VALUE IN HEALTH, 2010, 13 (06) : 726 - 734
  • [9] REPLY: Evaluating Statin Versus Statin Plus Ezetimibe for Coronary Plaque Regression
    Tsujita, Kenichi
    Sugiyama, Seigo
    Shimomura, Hideki
    Yamanaga, Kenshi
    Kaikita, Koichi
    Hokimoto, Seiji
    Ogawa, Hisao
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (25) : 2916 - 2917
  • [10] Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
    Abramson, Beth L.
    Benlian, Pascale
    Hanson, Mary E.
    Lin, Jianxin
    Shah, Arvind
    Tershakovec, Andrew M.
    [J]. LIPIDS IN HEALTH AND DISEASE, 2011, 10
12345